Clinical trials
Hyperlipidemias trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2007 | 5 |
| 2008 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 7 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Unknown status | 9 |
| Recruiting | 6 |
| Active, not recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Taiwan University Hospital | 4 |
| Novartis Pharmaceuticals | 4 |
| Amgen | 3 |
| AstraZeneca | 3 |
| Chang Gung Memorial Hospital | 3 |
| Pfizer | 3 |
| China Medical University Hospital | 2 |
| Chung Shan Medical University | 2 |
| Kastle Therapeutics, LLC | 2 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipidemias | 40 |
| Hypercholesterolemia | 10 |
| Cardiovascular Diseases | 8 |
| Dyslipidemias | 7 |
| Homozygous Familial Hypercholesterolemia | 5 |
| Hyperglycemia | 5 |
| Hypertension | 5 |
| Hyperlipoproteinemia Type II | 4 |
| Stroke | 4 |
| Diabetes Mellitus | 3 |
Trials
Showing 26 to 40 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.